NeuroPace, Inc. (NPCE)
14.66
+0.25
(+1.73%)
USD |
NASDAQ |
Aug 31, 16:00
14.66
0.00 (0.00%)
After-Hours: 20:00
NeuroPace Cash from Investing (Quarterly) : -0.125M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.125M |
| March 31, 2026 | -0.117M |
| December 31, 2025 | -0.097M |
| September 30, 2025 | -0.03M |
| June 30, 2025 | -0.168M |
| March 31, 2025 | -0.037M |
| December 31, 2024 | 1.961M |
| September 30, 2024 | 1.40M |
| June 30, 2024 | 3.237M |
| March 31, 2024 | 2.396M |
| December 31, 2023 | 3.468M |
| September 30, 2023 | 4.191M |
| June 30, 2023 | 5.30M |
| Date | Value |
|---|---|
| March 31, 2023 | 10.07M |
| December 31, 2022 | 8.898M |
| September 30, 2022 | 6.969M |
| June 30, 2022 | 8.236M |
| March 31, 2022 | -0.306M |
| December 31, 2021 | -0.154M |
| September 30, 2021 | -0.19M |
| June 30, 2021 | -80.02M |
| March 31, 2021 | -5.035M |
| December 31, 2020 | -10.05M |
| September 30, 2020 | -0.25M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -0.471M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | -87.34M |
| CVRx, Inc. | -0.112M |
| Accuray, Inc. | -1.353M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | -12.57M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.903M |
| Cash from Financing (Quarterly) | 1.176M |
| Free Cash Flow | -11.61M |
| Free Cash Flow Per Share (Quarterly) | -0.1181 |
| Free Cash Flow to Equity (Quarterly) | -3.497M |
| Free Cash Flow to Firm (Quarterly) | -2.489M |
| Free Cash Flow Yield | -2.36% |